Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
53.29
+0.04 (0.08%)
May 14, 2026, 9:42 AM EDT - Market open
Royalty Pharma Employees
Royalty Pharma had 100 employees as of December 31, 2025. The number of employees increased by 1 or 1.01% compared to the previous year.
Employees
100
Change (1Y)
1
Growth (1Y)
1.01%
Revenue / Employee
$24,405,220
Profits / Employee
$8,262,880
Market Cap
30.69B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | 1 | 1.01% |
| Dec 31, 2024 | 99 | 10 | 11.24% |
| Dec 31, 2023 | 89 | 14 | 18.67% |
| Dec 31, 2022 | 75 | 9 | 13.64% |
| Dec 31, 2021 | 66 | 15 | 29.41% |
| Dec 31, 2020 | 51 | 16 | 45.71% |
| Dec 31, 2019 | 35 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 3,088 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
RPRX News
- 20 hours ago - Royalty Pharma Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 days ago - Royalty Pharma to present at upcoming investor conferences - GlobeNewsWire
- 6 days ago - Royalty Pharma price target raised to $64 from $63 at Morgan Stanley - TheFly
- 6 days ago - Royalty Pharma price target raised to $58 from $50 at JPMorgan - TheFly
- 7 days ago - Royalty Pharma price target raised to $66 from $50 at Citi - TheFly
- 8 days ago - Royalty Pharma Earnings Call Transcript: Q1 2026 - Transcripts
- 8 days ago - Royalty Pharma reports first quarter 2026 results - GlobeNewsWire
- 12 days ago - An 8-Hour AI Result Is Testing Pharma's $10 Billion Royalty Market - Forbes